About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Nle1tm1.1Cota
targeted mutation 1.1, Michel Cohen-Tannoudji
MGI:5553357
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Nle1tm1Cba/Nle1tm1.1Cota
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+ 		involves: 129P2/OlaHsd * 129S2/SvPas MGI:5553371
cn2
 		Nle1tm1Cba/Nle1tm1.1Cota
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
Trp53tm1Tyj/Trp53tm1Tyj 		involves: 129P2/OlaHsd * 129S2/SvPas MGI:5553372
cn3
 		Nle1tm1Cba/Nle1tm1.1Cota
Cd19tm1(cre)Cgn/Cd19+ 		involves: 129P2/OlaHsd * 129S2/SvPas MGI:5553374


Genotype
MGI:5553371
cn1
Allelic
Composition		 Nle1tm1Cba/Nle1tm1.1Cota
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
Genetic
Background		 involves: 129P2/OlaHsd * 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2(cre/ERT2)Brn mutation (1 available); any Gt(ROSA)26Sor mutation (942 available)
Nle1tm1.1Cota mutation (0 available); any Nle1 mutation (27 available)
Nle1tm1Cba mutation (0 available); any Nle1 mutation (27 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype

Severe hypocellularity in Nle1tm1Cba/Nle1tm1.1Cota Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+ bone marrow, with capillaries saturated with erythrocytes

mortality/aging
premature death ( J:204063 )
• mice die 10 to 13 days after tamoxifen treatment

immune system
decreased granulocyte number ( J:204063 )
• in tamoxifen-treated mice
decreased NK cell number ( J:204063 )
• in tamoxifen-treated mice
decreased T cell number ( J:204063 )
• in tamoxifen-treated mice
decreased macrophage cell number ( J:204063 )
• in tamoxifen-treated mice
abnormal immune system organ morphology ( J:204063 )
• defects in secondary lymphoid organs in tamoxifen-treated mice
thymus hypoplasia ( J:204063 )
• in tamoxifen-treated mice
spleen hypoplasia ( J:204063 )
• in tamoxifen-treated mice

digestive/alimentary system
abnormal intestinal epithelium morphology ( J:204063 )
• 7 to 9 days after tamoxifen treatment

cellular
abnormal ribosome biogenesis ( J:204063 )
• tamoxifen-treated mice exhibit impaired biogenesis of large ribosomal subunit in hematopoietic stem cell and multipotent progenitor compared with control mice

hematopoietic system
hematopoietic system phenotype ( J:204063 )
N
• hematopoietic stem cell mobilization occurs normally in tamoxifen-treated mice
thymus hypoplasia ( J:204063 )
• in tamoxifen-treated mice
impaired hematopoiesis ( J:204063 )
• tamoxifen-treated mice exhibit cell autonomous defects in hematopoiesis
abnormal bone marrow cell morphology/development ( J:204063 )
• in tamoxifen-treated mice
• tamoxifen-treated mice exhibit impaired biogenesis of large ribosomal subunit in hematopoietic stem cell and multipotent progenitor compared with control mice
decreased bone marrow cell number ( J:204063 )
• severe in tamoxifen-treated mice
abnormal common lymphocyte progenitor cell morphology ( J:204063 )
• decreased in tamoxifen-treated mice
decreased granulocyte number ( J:204063 )
• in tamoxifen-treated mice
decreased NK cell number ( J:204063 )
• in tamoxifen-treated mice
decreased T cell number ( J:204063 )
• in tamoxifen-treated mice
decreased macrophage cell number ( J:204063 )
• in tamoxifen-treated mice
spleen hypoplasia ( J:204063 )
• in tamoxifen-treated mice
abnormal hematopoietic stem cell physiology ( J:204063 )
• reduced hematopoietic stem cell and multipotent progenitor quiescence in tamoxifen-treated mice

endocrine/exocrine glands
thymus hypoplasia ( J:204063 )
• in tamoxifen-treated mice




Genotype
MGI:5553372
cn2
Allelic
Composition		 Nle1tm1Cba/Nle1tm1.1Cota
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
Trp53tm1Tyj/Trp53tm1Tyj
Genetic
Background		 involves: 129P2/OlaHsd * 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2(cre/ERT2)Brn mutation (1 available); any Gt(ROSA)26Sor mutation (942 available)
Nle1tm1.1Cota mutation (0 available); any Nle1 mutation (27 available)
Nle1tm1Cba mutation (0 available); any Nle1 mutation (27 available)
Trp53tm1Tyj mutation (12 available); any Trp53 mutation (232 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
hematopoietic system phenotype ( J:204063 )
N
• tamoxifen-treated mice exhibit rescued total bone marrow and LSK cells




Genotype
MGI:5553374
cn3
Allelic
Composition		 Nle1tm1Cba/Nle1tm1.1Cota
Cd19tm1(cre)Cgn/Cd19+
Genetic
Background		 involves: 129P2/OlaHsd * 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (56 available)
Nle1tm1.1Cota mutation (0 available); any Nle1 mutation (27 available)
Nle1tm1Cba mutation (0 available); any Nle1 mutation (27 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
hematopoietic system phenotype ( J:204063 )
N
• mice exhibit normal numbers of bone marrow pre-B cells, immature B cells and splenic mature B cells
• mice exhibit normal survival, proliferation and maturation of restricted progenitors

immune system
immune system phenotype ( J:204063 )
N
• mice exhibit normal numbers of bone marrow pre-B cells, immature B cells and splenic mature B cells
• mice exhibit normal survival, proliferation and maturation of restricted progenitors




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory